Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Type
Research/project funding
Posted on:
Date limite d´inscription:
Expired
Reference Number
PAR-19-261
The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing male and/or female non-hormonal contraception developmentwith the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism, fertility studies). The purpose of this FOA is to provide investigators with a mechanism to request services from this facility that would advance their development program for either male or female contraceptives.
Categories: Income Security and Social Services, Health.
Categories: Income Security and Social Services, Health.
États-Unis